P-084: Bone marrow of patients post ASCT, but not chemotherapy consolidation, contains expanded T cell receptor clonotypes that are present at diagnosis: results from the Phase 2 CARDAMON studyKane Foster, Kwee Yong, Daria Galas‐Filipowicz et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 0
OAB-018: From CARDAMON to CoMMpass: a mutational signature that predicts carfilzomib-specific outcomes in myelomaIeuan Walker, Michael Chapman, Javier Herrero et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 0
P-390 The differentiation and expansion of T cell clonotypes in the bone marrow following ASCT: insights from the Phase 2 CARDAMON studyKane Foster, Kwee Yong, M.D. Chapman et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0
High Neoantigen Load Confers a Major Benefit from Autologous Stem Cell Transplantation Compared to Consolidation in Newly Diagnosed Multiple MyelomaIeuan Walker, Michael A. Chapman, Venetia D’arcy et al.|Blood|2023Cited by 0